vs
DHT Holdings, Inc.（DHT）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
DHT Holdings, Inc.的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.9倍（$107.3M vs $57.3M），DHT Holdings, Inc.净利率更高（41.7% vs -83.0%，领先124.7%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs -24.5%）
DHT控股是一家独立的国际原油运输企业，持有并运营大型原油运输船队，主要服务全球油气行业，为头部石油生产商、炼油厂和大宗商品贸易商提供跨国际核心贸易航线的原油海运服务。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
DHT vs RYTM — 直观对比
营收规模更大
DHT
是对方的1.9倍
$57.3M
营收增速更快
RYTM
高出61.3%
-24.5%
净利率更高
DHT
高出124.7%
-83.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.3M | $57.3M |
| 净利润 | $44.8M | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | 44.2% | -82.2% |
| 净利率 | 41.7% | -83.0% |
| 营收同比 | -24.5% | 36.9% |
| 净利润同比 | 27.3% | -9.6% |
| 每股收益（稀释后） | $0.28 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHTRYTM
| Q4 25 | — | $57.3M | ||
| Q3 25 | $107.3M | $51.3M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | — | $41.8M | ||
| Q3 24 | $142.1M | $33.3M | ||
| Q2 24 | — | $29.1M | ||
| Q1 24 | — | $26.0M |
净利润DHTRYTM
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $44.8M | $-52.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $35.2M | $-43.6M | ||
| Q2 24 | — | $-32.3M | ||
| Q1 24 | — | $-141.4M |
毛利率DHTRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
营业利润率DHTRYTM
| Q4 25 | — | -82.2% | ||
| Q3 25 | 44.2% | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | 29.7% | -132.0% | ||
| Q2 24 | — | -139.2% | ||
| Q1 24 | — | -538.7% |
净利率DHTRYTM
| Q4 25 | — | -83.0% | ||
| Q3 25 | 41.7% | -103.1% | ||
| Q2 25 | — | -96.1% | ||
| Q1 25 | — | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 24.8% | -131.2% | ||
| Q2 24 | — | -110.9% | ||
| Q1 24 | — | -544.4% |
每股收益（稀释后）DHTRYTM
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $0.28 | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | $0.22 | $-0.73 | ||
| Q2 24 | — | $-0.55 | ||
| Q1 24 | — | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.3M | $388.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $139.1M |
| 总资产 | $1.4B | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHTRYTM
| Q4 25 | — | $388.9M | ||
| Q3 25 | $81.3M | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | $73.8M | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
股东权益DHTRYTM
| Q4 25 | — | $139.1M | ||
| Q3 25 | $1.1B | $148.8M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $1.0B | $11.2M | ||
| Q2 24 | — | $39.3M | ||
| Q1 24 | — | $61.6M |
总资产DHTRYTM
| Q4 25 | — | $480.2M | ||
| Q3 25 | $1.4B | $506.9M | ||
| Q2 25 | — | $372.7M | ||
| Q1 25 | — | $386.7M | ||
| Q4 24 | — | $392.3M | ||
| Q3 24 | $1.5B | $363.6M | ||
| Q2 24 | — | $381.8M | ||
| Q1 24 | — | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.36× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DHTRYTM
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $60.9M | $-26.6M | ||
| Q2 25 | — | $-23.3M | ||
| Q1 25 | — | $-40.4M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $80.1M | $-25.2M | ||
| Q2 24 | — | $-29.1M | ||
| Q1 24 | — | $-40.7M |
现金转化率DHTRYTM
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
